Serial Number | 79153946 |
Word Mark | ANOCCA |
Filing Date | Wednesday, February 12, 2014 |
Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
Status Date | Tuesday, February 13, 2024 |
Registration Number | 4848434 |
Registration Date | Tuesday, November 10, 2015 |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, August 25, 2015 |
Description of Mark | The mark consists of the word "ANOCCA" in turquoise to the right of which is a turquoise circular design with two white vertical curved lines between wich is a white circle with a white horizontal curved line below the circle. |
Indication of Colors claimed | The color(s) turquoise and white is/are claimed as a feature of the mark. |
Translation of Words in Mark | The wording "ANOCCA" has no meaning in a foreign language. |
Goods and Services | Medical services; veterinary services; hygienic and beauty care for human beings or animals; analysis in the nature of medical testing of human serum for medical treatment; analysis in the nature of medical testing of human tissues for medical treatment; medical assistance services; DNA screening for medical purposes; genetic testing for medical purposes; technical consultancy services relating to medical health services; medical health clinic services; conducting of medical examinations for medical diagnostics or treatment purposes; medical examination of individuals for medical diagnostic or treatment purposes; provision of information relating to medicine; medical assistance consultancy provided by doctors and other specialized medical personnel; medical clinic services; consultancy services relating to personal behavior; emergency medical assistance; medical analysis services in the nature of genomic analysis for medical purposes; medical treatment services; medical health assessment services; services for the provision of medical care information; medical advisory services; medical screening; medical screening relating to the heart; ambulant medical care; medical clinic services; medical services for the treatment of conditions of the human body; medical services for the diagnosis of conditions of the human body; medical services for the diagnosis of immuno-biological conditions; medical healthcare consultancy services in the field of immuno-biological conditions; medical advisory services relating to medical problems; providing information to patients in the field of administering medications; services for the provision of medical care information; provision of medical services; providing news and information in the field of medicine; providing medical information to patients, medical professionals, medical research institutions and pharmaceutical companies in the form issuing of medical reports in the field of immuno-biological conditions, namely, allergies, auto-immune conditions and immune evasion conditions; charitable services, namely, providing medical services to underserved communities; charitable services, namely, providing medical services to needy persons |
Goods and Services | Scientific and technological services and research and design in the field of pharmaceuticals, medical diagnostics, therapeutics, vaccines, genome editing, recombinant DNA technologies, immunology and immunorecognition; analysis of human serum for medical research; analysis of human tissues for medical research; biological research, clinical research and medical research; research on the subject of pharmaceuticals; medical and pharmacological research services; medical research laboratory services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; development of pharmaceutical preparations and medicines; scientific research for medical purposes in the area of cancerous diseases |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, May 27, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, May 27, 2022 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Anocca AB |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | SE |
Party Name | Anocca AB |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | SE |
Party Name | Anocca AB |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | SE |
Event Date | Event Description |
Tuesday, November 4, 2014 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Thursday, October 30, 2014 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Monday, November 3, 2014 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, November 3, 2014 | ASSIGNED TO EXAMINER |
Monday, November 3, 2014 | NON-FINAL ACTION WRITTEN |
Tuesday, November 4, 2014 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Tuesday, November 4, 2014 | REFUSAL PROCESSED BY MPU |
Friday, July 3, 2015 | EXAMINERS AMENDMENT -WRITTEN |
Friday, November 7, 2014 | APPLICATION FILING RECEIPT MAILED |
Friday, November 21, 2014 | REFUSAL PROCESSED BY IB |
Wednesday, December 17, 2014 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, December 17, 2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, December 17, 2014 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, January 22, 2015 | FINAL REFUSAL WRITTEN |
Thursday, January 22, 2015 | FINAL REFUSAL MAILED |
Wednesday, June 17, 2015 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Wednesday, June 17, 2015 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Friday, July 3, 2015 | EXAMINERS AMENDMENT E-MAILED |
Friday, July 3, 2015 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Friday, July 3, 2015 | EXAMINER'S AMENDMENT ENTERED |
Friday, July 3, 2015 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, August 21, 2015 | NOTIFICATION PROCESSED BY IB |
Monday, July 20, 2015 | ASSIGNED TO LIE |
Monday, July 20, 2015 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Wednesday, August 5, 2015 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Wednesday, August 5, 2015 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Wednesday, August 5, 2015 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Thursday, March 7, 2019 | NEW REPRESENTATIVE AT IB RECEIVED |
Tuesday, August 25, 2015 | PUBLISHED FOR OPPOSITION |
Tuesday, August 25, 2015 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, November 10, 2015 | REGISTERED-PRINCIPAL REGISTER |
Wednesday, February 10, 2016 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Monday, March 7, 2016 | FINAL DISPOSITION PROCESSED |
Monday, March 7, 2016 | FINAL DISPOSITION NOTICE SENT TO IB |
Friday, March 25, 2016 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Monday, November 12, 2018 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Monday, November 12, 2018 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Tuesday, November 10, 2020 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
Thursday, October 28, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
Friday, March 17, 2023 | INVALIDATION PROCESSED |
Friday, May 27, 2022 | CANCELLED SECTION 71 |
Saturday, June 11, 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
Friday, January 27, 2023 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
Saturday, August 31, 2024 | DEATH OF INTERNATIONAL REGISTRATION |
Saturday, August 31, 2024 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED |
Wednesday, April 12, 2023 | TOTAL INVALIDATION PROCESSED BY THE IB |
Saturday, March 18, 2023 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |